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ABSTRACT
Objective To establish the feasibility of a multicentre 
randomised controlled trial to assess the effectiveness 
and cost- effectiveness of a non- operative treatment 
pathway compared with appendicectomy in children with 
uncomplicated acute appendicitis.
Design Feasibility randomised controlled trial with 
embedded qualitative study to inform recruiter training 
to optimise recruitment and the design of a future 
definitive trial.
Setting Three specialist paediatric surgery centres in 
the UK.
Patients Children (aged 4–15 years) with a clinical 
diagnosis of uncomplicated acute appendicitis.
Interventions Appendicectomy or a non- operative 
treatment pathway (comprising broad- spectrum 
antibiotics and active observation).
Main outcome measures Primary outcome 
measure was the proportion of eligible patients 
recruited. Secondary outcomes evaluated adherence to 
interventions, data collection during follow- up, safety of 
treatment pathways and clinical course.
Results Fifty per cent of eligible participants (95% CI 
40 to 59) approached about the trial agreed to 
participate and were randomised. Repeated bespoke 
recruiter training was associated with an increase in 
recruitment rate over the course of the trial from 38% 
to 72%. There was high acceptance of randomisation, 
good patient and surgeon adherence to trial procedures 
and satisfactory completion of follow- up. Although more 
participants had perforated appendicitis than had been 
anticipated, treatment pathways were found to be safe 
and adverse event profiles acceptable.
Conclusion Recruitment to a randomised controlled 
trial examining the effectiveness and cost- effectiveness 
of a non- operative treatment pathway compared with 
appendicectomy for the treatment of uncomplicated 
acute appendicitis in children is feasible.
Trial registration number ISRCTN15830435.
INTRODUCTION
Acute appendicitis is the most common surgical 
emergency in children and is most frequently 
treated with appendicectomy. Recently non- 
operative treatment of appendicitis (with anti-
biotics alone and without an appendicectomy) 
has come to the fore as an alternate treatment 
approach but has not yet entered mainstream 
clinical practice. Barriers to the more widespread 
adoption of non- operative treatment include 
concerns over safety and efficacy and the fact that 
many surgeons are unfamiliar with this treatment 
strategy. Although appendicectomy is a tried and 
tested treatment, is familiar to surgeons and has 
a well- understood safety and efficacy profile, it 
does require a general anaesthetic and an abdom-
inal operation with inherent risks. Many parents 
find the proposal that their child needs emer-
gency surgery frightening and one they are keen 
to avoid if a viable alternative is available. While 
the existing evidence supports the safety of non- 
operative treatment,1 there is an evidence gap 
preventing meaningful comparison of the effec-
tiveness and cost effectiveness of these treatment 
What is already known on this topic?
 ► Non- operative treatment is an alternative 
to appendicectomy for children with 
uncomplicated acute appendicitis but the 
comparative effectiveness of these treatments 
is not known.
 ► A randomised trial comparing these treatments 
will be challenging due to the urgent care 
setting, complex treatments interventions and 
patient and surgeon preferences.
 ► Feasibility studies can help establish the 
feasibility of future RCTs and enhance their 
design to optimise chances of success and 
minimise waste of resources.
What this study adds?
 ► A future RCT comparing the effectiveness and 
cost- effectiveness of non- operative treatment 
with appendicectomy for children with 
uncomplicated acute appendicitis is feasible.
 ► Supported by embedded qualitative research to 
inform communication and recruiter training, 
we have identified opportunities to improve 
design and implementation of the future RCT.
 ► Hard to do trials where potentially eligible 
children often attend at night are feasible and 
acceptable particularly with iterative training 
for recruiters.  on A
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approaches;2 in particular, there is a lack of well- designed 
randomised controlled trials (RCTs) comparing appendicec-
tomy with non- operative treatment.
In order to conduct an adequately powered pragmatic RCT, 
we first identified the need for further information on the feasi-
bility of recruiting children to a RCT comparing appendicec-
tomy with non- operative treatment. Issues to consider include: a 
lack of experience with non- operative treatment of acute appen-
dicitis in the UK, so that surgeons may not be willing to recruit, 
and a challenging trial recruitment profile. Specifically, such a 
trial would involve recruiting children presenting acutely (often 
out of normal working hours), explaining a trial that has two 
very different treatment pathways in a time- limited setting, and 
relying on clinical staff with little trials experience to recruit to 
the trial in an unscheduled care setting. Furthermore, we iden-
tified several uncertainties regarding the design of a definitive 
effectiveness trial, not least the selection of appropriate primary 
and secondary outcomes.
We therefore performed a feasibility RCT with an embedded 
qualitative study. The aims were (i) to test feasibility of recruitment 
to an RCT of acute uncomplicated appendicitis in children in the 
UK, from both a patient and surgeon perspective; (ii) to optimise 
recruitment into the trial; (iii) to confirm the performance and 
safety of treatment pathways and (iv) to inform the design of a 
future definitive RCT. The detailed methods and results of the 
embedded qualitative study are reported elsewhere.3 The feasi-
bility RCT was part of the CONservative TReatment of Appen-
dicitis in Children randomised controlled Trial (CONTRACT) 
(feasibility) study that also included the development of a core 
outcome set for research involving children with uncomplicated 
appendicitis to identify outcomes important to a range of stake-
holders, and a health economic feasibility study (both reported 
elsewhere).4–6 Here, we report key outcomes from the feasibility 
trial, which inform the viability of a future RCT, and key related 
findings from the embedded qualitative study.
METHODS
This feasibility RCT comparing appendicectomy and non- 
operative treatment in children with uncomplicated acute 
appendicitis was conducted in three specialist paediatric surgery 
centres in England and in accordance with a publicly available 
protocol.7
Participants
Children aged >3 and<16 years with a clinical diagnosis, 
with or without radiological assessment, of uncomplicated 
acute appendicitis which prior to study commencement would 
be treated with appendicectomy, were eligible for inclusion. 
Exclusion criteria were: clinical signs or radiological findings 
to suggest perforated appendicitis; presentation with appendix 
mass; previous episode of appendicitis or appendix mass treated 
non- operatively; major anaesthetic risk precluding allocation to 
the appendicectomy arm; a known antibiotic allergy preventing 
allocation to non- operative treatment arm; antibiotic treat-
ment started at referring institution (defined as two or more 
doses administered); cystic fibrosis; a positive pregnancy test 
or current treatment for malignancy. Of note, there was no 
requirement for diagnostic imaging in this study since imaging 
is not routinely used in the diagnostic evaluation of children 
suspected to have appendicitis in the UK8 9 and we wished to 
replicate current diagnostic pathways and deliver a pragmatic 
trial as far as possible.
Participant identification, recruitment, randomisation
Participants were identified by the clinical team at the time of 
diagnosis and eligibility was confirmed by the research team 
as soon as possible. Eligible patients were approached by the 
treating clinical teams with support from dedicated research 
nurses. Potential participants were provided with written infor-
mation about the study and shown a short video describing the 
study (available at http:/ tinyurl. com/ contract- f). From the time 
of first discussing the trial with potential participants and their 
families a maximum of 4 hours was permitted before a decision 
could be made regarding participation. This was to ensure there 
was no delay in providing treatment as a result of considering 
trial participation.
After written informed consent (and assent from children 
aged 12 years or over who wished to give it), a member of the 
trial team randomised the participant to one of two treatment 
groups in a 1:1 ratio via an independent web- based system, mini-
mising for recruiting centre, sex (male/female), age (4–8/9–15) 
and duration of symptoms (onset of pain to recruitment into 
study) (<48 hours/≥48 hours), with complete prerandomisation 
concealment of treatment allocation. Participants were informed 
of their treatment allocation immediately.
Interventions
Non-operative treatment arm
Children randomised to non- operative treatment were treated 
according to a clinical pathway designed specifically for this 
trial: fluid resuscitation, a minimum of 24 hours broad spec-
trum intravenous antibiotics (per local antimicrobial policy), a 
minimum of 12 hours nil by mouth (NBM) and regular clinical 
review to detect signs and symptoms of significant clinical deteri-
oration (including, but not limited to, increasing fever, increasing 
tachycardia and increasing tenderness). After the initial 12- hour 
period of NBM, oral intake was advanced as tolerated. Children 
successfully treated without an operation were converted to oral 
antibiotics (per local policy) once they are afebrile for 24 hours 
and tolerating oral intake.
Clinical reviews were completed at approximately 24 and 48 
hours postrandomisation. Any child who showed signs of signif-
icant clinical deterioration by 24 hours, or at any point during 
the trial, wase treated with appendicectomy. Children who were 
considered stable or improving continued with non- operative 
treatment. At 48 hours, any child who had not shown clinical 
improvement was scheduled for an appendicectomy. The deci-
sion to continue non- operative treatment at these time points 
or to recommend discontinuation of non- operative treatment 
and appendicectomy was made by the treating consultant based 
on clinical judgement. All reasons for change in treatment were 
recorded in detail in order to guide a clinical pathway in a future 
trial.
Any child who received an appendicectomy for an incomplete 
response to non- operative treatment, followed a standardised 
postoperative treatment regime already in use at each institu-
tion and identical to that used in the appendicectomy arm. The 
reason for having an appendicectomy was recorded.
Children treated non- operatively received a total of 10 days 
antibiotics following randomisation unless decided otherwise 
by the treating clinician. Children who received non- operative 
treatment were not offered interval appendicectomy but were 
counselled about the risk of recurrence.
Appendicectomy treatment arm
Children randomised to the appendicectomy arm underwent 
either open or laparoscopic appendicectomy at the surgeon’s 
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discretion, performed by a suitably experienced trainee (as per 
routine current practice) or a consultant. Participants received 
intravenous antibiotics from the time of diagnosis and were 
treated postoperatively with intravenous antibiotics according 
to existing institutional protocols. The duration of antibiotic 
therapy was not standardised due to anticipated variation in 
intraoperative findings and in response to treatment. The type of 
antibiotics used was identical to those used in the non- operative 
treatment arm within each centre. Any child failing to respond 
to first- line antibiotics was treated as clinically appropriate with 
a longer course of antibiotics or a change in antibiotic therapy 
determined by intraoperative swab or fluid culture. Postoper-
atively, children with uncomplicated acute appendicitis or a 
normal appendix did not routinely have a nasogastric tube or 
a urinary catheter. They received oral intake as tolerated after 
surgery.
The clinical pathway for the two treatment arms is shown in 
figure 1. The schedule of enrolment, interventions and follow- up 
has been previously reported.7
Discharge assessment
Criteria for discharge home were the same in each treatment arm: 
vital signs within normal limits for age, afebrile for ≥24 hour, 
tolerating light diet orally, adequate oral pain relief and able to 
mobilise. Parents of all participants were given an information 
sheet at discharge informing them of ‘red flag’ symptoms and 
advised to contact their local unit if they had concerns about 
their child’s clinical progress.
Follow-up and data collection
Participants were asked to complete a diary card for the first 14 
days following hospital discharge about: medication taken (anti-
biotics and analgesia), whether they had been able to return to 
normal activity or full activity that day and if their parent(s) had 
had to take time off work because of their appendicitis. A clinic 
follow- up visit took place at 6 weeks with further trial follow- up 
at 3 and 6 months following discharge, either in the outpatient 
clinic or in the clinical research facility at each centre. If a face- 
to- face appointment was not possible, the 3- month and 6- month 
Figure 1 Clinical treatment pathway for each arm. *Appendicectomy group—no routine use of nasogastric tube or urinary catheter, advance diet 
as tolerates. †Non- operative treatment=NBM/sips for initial 12 hours minimum, then advance diet as tolerates; intravenous antibiotics 24 hours 
minimum, change to oral once afebrile for 24 hours, total course 10 days; analgesia. ‡Defined as either seeing a hole in the appendix or faecal matter/
faecolith in the peritoneal cavity. §Continue intravenous antibiotics until afebrile for 24 hours, then change to oral; minimum 5 days total antibiotics. 
¶Criteria for discharge include: vital signs within normal limits, tolerating light diet, adequate oral analgesia, mobile. NBM, nil by mouth.
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follow- up were completed by telephone. Data were recorded by 
dedicated research nurses at each site during hospital admissions 
and trial follow- up directly into an electronic, secure, web- based 
case report form.
Primary outcome
The primary outcome was the recruitment rate into the trial 
defined as the proportion of eligible participants who were 
approached and recruited to the study over 12 months.
Secondary outcomes
The secondary outcomes were:
1. Performance of study procedures including retention of par-
ticipants for the duration of the study, and feasibility of out-
come recording and data collection systems.
2. Willingness of parents, children and surgeons to take part 
in a randomised study comparing operative versus non- 
operative treatment and identify anticipated recruitment 
rate. This was assessed from audio recorded family- surgeon 
recruitment consultations, interviews with patients, parents, 
surgeons and nurses, surgeon surveys and focus groups.
3. Clinical outcomes of trial treatment pathways including (i) 
safety and overall success of initial non- operative treatment 
(measured as the number of patients randomised to non- 
operative treatment, discharged from hospital without ap-
pendicectomy); (ii) complications of disease and treatment 
(measured during hospital stay and 6- month follow- up pe-
riod); (iii) rate of recurrent appendicitis during 6- month 
follow- up period. Further details of these outcomes includ-
ing timing and method of measurement can be found in the 
published trial protocol.7
Blinding of treatment arm was not considered ethical or 
feasible, so treating staff, parents and participants were aware 
of treatment allocation. We aimed to determine the feasibility of 
a blinded discharge assessment and therefore blinded outcome 
assessment in a future RCT by attempting to complete a blinded 
discharge assessment for each participant. Once a decision to 
discharge the child had been made a member of the clinical team 
who had not been involved directly in the child’s treatment was 
asked to complete a discharge assessment. This assessor did 
not have prior knowledge of the randomisation or treatment 
received by the child. On completion of the discharge assess-
ment, the assessor ‘guessed’ which treatment the child received. 
If the assessor became unblinded during the assessment, this was 
recorded.
Sample size and statistical analysis
As a feasibility study, we did not specify a specific sample size but 
aimed to define our recruitment rate within an approximate 10% 
margin of error. Based on an anticipated study population avail-
able for recruitment of approximately 130 eligible participants 
across the three participating centres, we would be able to esti-
mate a true 40% recruitment rate with a 95% CI of 31%–49% 
and a true 50% recruitment rate with a 95% CI of 41%–59%. 
These numbers of participants in the feasibility RCT would be 
adequate to test treatment pathway procedures, data collection 
methods and loss to follow- up. Accordingly, the study duration 
was defined a priori as being 12 months.
Data analysis was performed by the study statistician who 
was blinded to treatment allocation by the use of coded data. As 
this is a feasibility study, all analyses were treated as preliminary 
and exploratory, and data are reported descriptively. Feasibility 
outcomes (number of eligible patients, recruitment/retention 
rates, reasons for non- participation, success of blinding of the 
discharge assessor), treatment outcomes and complications are 
presented as simple summary statistics with 95% CI.
Embedded qualitative study
Full methods and outcomes of this have been published else-
where.3 The main aim of the qualitative study was to optimise 
trial recruitment on an iterative basis while the feasibility trial 
was still open to recruitment. Before recruitment started, we 
delivered generic communication training, informed by trial 
communication literature, to recruiting health professionals at 
all three trial sites. We subsequently developed bespoke commu-
nication training informed by the ongoing thematic analysis of 
the qualitative data, which comprised recruitment consultations 
and interviews with families and staff. Training was delivered 
to sites at the end of month 4 of recruitment and again during 
month 9 of recruitment. The potential impact of the qualita-
tive study was evaluated by determining recruitment rates across 
three phases of the study: ‘phase one’ being the first 4 months 
(March to June 2017), ‘phase two’ months 5–9 and ‘phase three’ 
as the final 3 months.
Trial governance
A Study Management Group was responsible for overseeing 
the day- to- day management of the trial. An independent Trial 
Steering Committee and Data Monitoring and Safety Committee 
were convened to provide oversight of the study. Their roles and 
responsibilities which included adverse event monitoring were 
agreed at the beginning of the trial and documented in specific 
charters. Specific processes to report adverse events in a timely 
manner to the relevant committee were agreed.
The trial was carried out in accordance with a published 
protocol that was developed in accordance with the SPIRIT- C 
guidance, was registered prior to recruitment of the first partic-
ipant (ISRCTN 15830435) and has been published previously.7 
The study is reported in accordance with the CONSORT 2010 
statement (feasibility trial extension).10
Changes to the study from the original protocol
Following an analysis of follow- up rates during the study, we 
introduced an incentive to improve follow- up rates and improve 
ascertainment of follow- up data. This was introduced in March 
2018 following a successful application to the ethics committee 
to make this amendment. All participants who attended all 
remaining follow- up visits from that point onwards were offered 
a £10 voucher. The impact of this was assessed.
Patient and public involvement
The methodology for this feasibility trial was developed with 
a study specific advisory group comprising young people and 
parents, many of whom had experience of acute appendicitis. 
These were invited to join this group through existing regional 
young person’s advisory groups and through contacts of the clin-
ical investigators. This group met prior to the start of the study 
and again regularly throughout its duration. The group oversaw 
all aspects of the trial that involved interaction with patients 
and families including all patient and family facing documen-
tation (eg, patient information sheets, consent forms, discharge 
information leaflets), the recruitment video, method and timing 
of initial approach for recruitment conversation and interview 
topic guides for the embedded qualitative research.
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RESULTS
All three centres opened to recruitment simultaneously on 1 
March 2017 and were open to recruitment for 12 months until 
28 February 2018. Final follow- up was completed on 31 August 
2018. The trial profile is shown in figure 2.
Recruitment and participants
Of 275 children screened, 131 fulfilled the eligibility criteria of 
whom 115 were approached about the study and of these 57 
agreed to participate and were randomised. Thus, the primary 
outcome (proportion of eligible patients who were approached 
Figure 2 CONSORT diagram of CONTRACT feasibility RCT. *Indicates withdrew from allocated treatment and withdrew consent for further data 
collection and therefore not included in further reporting. CONTRACT, CONservative TReatment of Appendicitis in Children randomised controlled Trial.
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and recruited) was 44% (95% CI 35 to 52), and recruitment 
rate of those approached was 50% (95% CI 40 to 59). Despite 
anticipated challenges in recruitment, participants were success-
fully recruited into the trial outside of normal working hours 
(40% were recruited between the hours of 18:00 and 08:00 
hours), recruitment rate per site across the whole study period 
ranged from 45% to 56% of those approached, and a total of 
21 different surgeons successfully recruited participants. Of 
57 participants randomised, baseline characteristics were well 
matched (table 1).
Interventions received
Figure 2 shows participant flow through the clinical trial. Three 
participants withdrew consent for the study soon after rando-
misation including consent for continued data collection. They 
were therefore excluded from any further analysis. Reasons given 
for this were dissatisfaction with treatment allocated (n=2) and 
being too overwhelmed with the diagnosis to continue in the 
trial (n=1). The remaining 27 participants in the appendicec-
tomy and 27 participants in the non- operative treatment arm 
both started the assigned intervention. All 27 participants in the 
appendicectomy received the allocated treatment whereas there 
was one protocol deviation in the non- operative treatment in a 
child whose parents withdrew consent for the study (but agreed 
to continued data collection) and requested appendicectomy 
8 hours after randomisation.
In the appendicectomy arm, all 27 children received the 
allocated intervention and were treated according to the clin-
ical pathway. Histological diagnosis of the resected appendix 
revealed uncomplicated acute appendicitis in 17 (63%), perfo-
rated appendicitis in 8 (30%) and a normal appendix in 2 (7%).
In the non- operative treatment arm, 19 of the 27 chil-
dren (70%) responded successfully to non- operative treat-
ment, followed the clinical pathway and were discharged from 
hospital. The remaining eight children underwent appendi-
cectomy during their initial hospital admission. Reasons for 
appendicectomy were parental choice (withdrawal from treat-
ment arm as described above) at 8 hours following randomis-
ation (n=1), deterioration in clinical condition (according to 
protocol) at range 12–44 hours following randomisation (n=6) 
and no improvement after 48 hours of non- operative treatment 
(in accordance with protocol, n=1). In the children who deterio-
rated (n=6), clinical reasons given included persistent fever and 
pain, worsening peritonism and worsening pain. In the one child 
who did not have any symptomatic improvement after 48 hours, 
the primary persisting complaint was that of ongoing severe 
abdominal pain. All these eight patients underwent successful 
appendicectomy during the initial hospital admission. Histolog-
ical findings were uncomplicated acute appendicitis in four and 
perforated appendicitis in four (all of whom had deteriorated 
during initial non- operative treatment).
Discharge assessment and follow-up
Thirty- four of 54 eligible children (63%) underwent a blinded 
discharge assessment. In the remaining 20, this was not possible 
due to non- availability of appropriate members of staff. In one 
case, the assessor was unblinded during the assessment. Following 
discharge, 26 of 54 (48%) participants (15 in the appendicec-
tomy arm and 11 in the non- operative treatment arm) returned a 
diary card, the majority of which (n=23, 88%) were completed 
in full. One child was completely lost to follow- up and did 
not attend any follow- up appointment or could be contacted 
by phone. This child was withdrawn from the study after the 
3- month follow- up timepoint as they were known to have 
moved overseas. The remaining participants attended follow- up 
appointments or were contacted by phone at 6 weeks (n=48/54, 
89% of those remaining in the study), 3 months (n=46/54, 85%) 
and 6 months (n=45/53, 85%). All other participants either did 
not attend or did not respond to repeated requests for contact 
by telephone.
Part way through the study, we introduced an incentive of a 
£10 shopping voucher to participants who completed all future 
follow- up assessments. Of the 3- month follow- up appointments, 
47 were not incentivised and were completed by 39 participants 
(83%, 95% CI 72% to 93%), whereas 7 were incentivised and 
all 7 were completed (100%, 95% CI 59% to 100%). Of the 
6- month follow- up appointments, 34 were not incentivised and 
were completed by 28 participants (83%, 95% CI 65% to 93%) 
and 19 were incentivised and were completed by 17 participants 
(89%, 95% CI 67% to 99%).
Secondary outcomes
There was no mortality in the 6 months following enrolment. 
During the 6- month follow- up, seven children in the non- 
operative treatment arm developed recurrent appendicitis (24% 
of those randomised to non- operative treatment; 37% of the 
19 who initially responded to non- operative treatment). Six of 
the seven underwent appendicectomy, with histological findings 
of simple acute appendicitis (n=4) and perforated appendicitis 
(n=2). The remaining participant presented with an appendix 
mass at the time of recurrence, which was successfully treated 
non- operatively and subsequently underwent interval lapa-
roscopic appendicectomy. At the final follow- up, 11 children 
initially randomised to receive non- operative treatment (41%) 
had not undergone appendicectomy. In the appendicectomy 
arm, three children (11%) were readmitted to hospital following 
initial treatment for treatment with intravenous antibiotics 
for fever and abdominal pain (n=1) or intra- abdominal fluid 







Age 10 years 7 months (6 
years 4 months to 13 
years 6 months)
10 years 3 months 
(5 years 0 months 
to 15 years 
11 months)
10 years 5 months 
(5 years 0 months 
to 15 years 
11 months)
Sex M:F (n) 18:10 18:10* 36:20*
Duration of 
symptoms (hours)†




8 (29%) 8 (28%)* 16 (28%)
Alvarado score†,§ 5 (3–8) 5 (3–8) 5 (3–8)
Data are median (range) unless otherwise specified.
*Data for one participant who withdrew after randomisation not available.
†Note that there were some missing data for duration of symptoms and Alvarado 
score; for duration of symptoms, data are missing for 10 in appendicectomy arm 
and 8 (including one withdrawal) in non- operative treatment arm; for Alvarado 
score, data are missing for five (including one withdrawal) in non- operative 
treatment arm.
‡No child had a CT scan as part of diagnostic workup.
§The Alvarado score22 is a tool used to assess the likelihood of appendicitis in 
children presenting with abdominal pain. It was calculated for participants to 
provide a quantitative measure of severity of illness but was not used to determine 
eligibility for the trial or as a minimisation criteria.
US, ultrasound.
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collection/abscess (n=2) including one child also treated with 
percutaneous drainage.
Adverse events during the 6- month follow- up are summarised 
in table 2. In the appendicectomy arm, 22 adverse events were 
reported in eight participants and in the non- operative treatment 
arm, 24 adverse events were reported in 15 participants. Of these, 
a small number were assigned as ‘possibly’ or ‘definitely’ attributed 
to the study intervention including: a rash at the time of receiving 
antibiotics (n=2), wound complications (dehiscence x1, infection 
x1, suture complications x1) and intra- abdominal fluid collections 
treated with drainage and antibiotics (n=1) or antibiotics alone 
(n=1).
Table 2 Adverse event (AE) profile of each treatment group
Subject AE description AE actions AE severity AE serious*
AE related to 
treatment arm AE outcome
A: non- operative treatment group
009 Fever- readmission Further course of antibiotics given Moderate Yes* Definitely Resolved with sequelae
PICC line insertion Weekly follow up appointments in clinic Moderate No Unrelated Resolved
025 Abdominal pain – Moderate Yes* Unrelated Resolved
Sore throat Ibuprofen given Mild No Unrelated Resolved
103 Abdominal pain Antibiotics Moderate Yes* Unlikely Resolved
Recurrent appendicitis Appendicectomy Severe Yes* Unlikely Resolved
162 Abdominal pain Appendicectomy and hospital admission Moderate No Definitely Ongoing
Fluid collection Continued antibiotics. Already in hospital Moderate No Definitely Ongoing
179 Abdominal pain A&E attendance, bloods taken Mild No Unrelated Resolved
233 Abdominal pain Appendicectomy and hospital admission Moderate No Definitely Resolved
Recurrence of appendicitis Appendicectomy Moderate No Definitely Resolved
266 Recurrent appendicitis Appendicectomy Moderate No Definitely Resolved
002 Abdominal pain Admission to hospital Mild No Probably Resolved
157 Abdominal pain – Moderate No Possibly Resolved
049 Abdominal pain Advice given in A&E Mild No Unrelated Resolved
089 Patient visited GP surgery complaining of 
being sleepy for 2 weeks
None Mild No Possibly Ongoing
Patient visited GP complaining of lethargy for 
2 weeks
None Mild No Possibly Ongoing
Abdomen pain Patient had appendicectomy Moderate No Probably Resolved
184 Abdominal pain Patient to be sent a clinic appointment Mild No Unlikely Ongoing
185 Rash over thighs Patient given three doses of antihistamine Mild No Unrelated Resolved
276 Lethargic Attended A+E. Discharged. Seen in clinic Mild No Probably Resolved
289 Generalised rash Started antihistamines Mild No   Possibly Resolved
B: Appendicectomy           
014 Abdominal pain Intravenous antibiotics Moderate Yes Possibly Resolved
Fever postop on readmission NA Mild No Possibly Resolved
017 Vomiting Ultrasound scan Moderate Yes Unlikely Resolved
123 Headache Paracetamol given Mild No Unrelated Resolved
Abdominal pain Blood test Moderate No Possibly Resolved
Intermittent vomiting Blood test taken on 06/11/2017 was fine Moderate No Possibly Resolved
Headache Ibuprofen, time off school Mild No Possibly Resolved
Sickness Rest, off sick from school – No Possibly Resolved
Sickness Surgical review Mild No Unrelated Resolved
Sickness Off school Mild No Unrelated Resolved
264 Fluid collection Drain insertion and hospitalisation Moderate No Unrelated Resolved
PICC line insertion Hospitalisation Moderate No Unrelated Resolved
Drain insertion Hospitalisation Moderate No Unrelated Resolved
040 Localised intra- abdominal fluid collection Treatment with intravenous antibiotics Moderate No Possibly Resolved
167 Inflamed wound site Patient started oral flucloxacillin Moderate No Definitely Resolved with sequelae
Wound dehiscence Attended accident and emergency Moderate No Definitely Resolved
Diarrhoea Telephone consultation with GP Mild No Unlikely Resolved with sequelae
Vomiting Call to GP—stomach bug diagnosed Mild No Unrelated Resolved
Diarrhoea Call to GP—stool sample Mild No Unrelated Resolved
Pharyngitis Started oral amoxicillin Mild No Unrelated Resolved
245 Wound infection Started antibiotics Moderate No Definitely Resolved
247 Suture- related complication Ultrasound and clinic appointment Moderate No Probably Resolved
PICC, peripherally inserted central venous catheter; GP, general practitioner.
*Note that AEs that were reported as serious (SAEs) during the early months of the trial are included here as reported on the basis of standardised reporting terminology in RCTs in that they 
resulted in either prolongation of hospital stay, readmission to hospital or death. However, since these were all predictable and related more to the disease process rather than the study 
interventions, we subsequently reclassified these ‘expected’ SAEs as AEs in protocol amendment 1 10 April 2017. Thus, although similar AEs did occur beyond the first 2 months of the study, they 
were no longer reported as SAEs.
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Embedded qualitative study
The findings of the qualitative study are reported elsewhere.3 
These findings shaped the first bespoke training session at the 
end of month 4, which focused on encouraging health profes-
sionals to use terminology that conveyed equipoise, exploring 
family treatment preferences and providing balancing infor-
mation and supported health professionals in responding to 
frequently asked questions from families. The second bespoke 
communication training session in month 9 (again informed by 
qualitative study findings) focused on ways that surgeons had 
improved their communication about CONTRACT since the 
first training, particularly with regard to equipoise. We also revis-
ited examples of non- optimal communication as well as ways to 
enhance explanations of randomisation, manage families’ expec-
tations about scheduling of surgery if non- operative treatment 
failed, provide balanced communication of treatment risks, (ie, 
discuss risks relating to both treatment arms) and respond to 
families’ further questions (see full report in Ref. 3). Recruitment 
rate increased following each of these bespoke training sessions 
from 38% during the initial 4 months to 47% in months 5–9 
and to 72% in months 10–12. Final recommendations from 
the qualitative study to inform the design of a future definitive 
trial, and paediatric urgent care surgical trials more broadly, are 
summarised in box 1.
DISCUSSION
To our knowledge, this is the first study to determine the 
feasibility of recruiting children with uncomplicated acute 
appendicitis to a RCT comparing appendicectomy with a non- 
operative treatment pathway. Our results show that it is possible 
to identify and recruit children with uncomplicated acute appen-
dicitis even outside of normal working hours (an important 
consideration since children with appendicitis frequently present 
at night and at the weekend). We achieved this by integrating the 
research protocol with clinical teams. The study conduct was 
good too. Paediatric surgeons adhered to the randomised alloca-
tion and patients and families reported that trial pathways and 
follow- up were good and acceptable. The qualitative work iden-
tified training requirements of clinical teams and this allowed 
trial specific training packages to be developed to optimise 
communication and recruitment. Overall, our findings support 
proceeding to a full definitive RCT to determine the comparative 
effectiveness of appendicectomy and non- operative treatment.
The main strength of this study is that we have established 
that a future RCT is possible by successfully recruiting to a 
feasibility RCT. A further strength is that we demonstrated this 
in three geographically and sociodemographically distinct UK 
centres with three different groups of surgeons. Additionally, we 
embedded qualitative methodology to develop bespoke training 
for recruiting teams and implemented this to optimise communi-
cation and recruitment within the study. The principal limitation 
is that we have conducted the work only in three centres and 
these may not be representative of future sites. However, addi-
tional work we have completed with other sites suggests there 
is adequate interest to proceed with a larger trial and we will 
ensure adequate support and training for clinical and research 
teams at new sites for our future RCT including through the 
NIHR Clinical Research Network.
In keeping with previous studies that have evaluated 
recruitment of children to RCTs in urgent care settings, we 
found that parental uptake was adequately high to make a 
future trial feasible.11 12 Our study of children with acute 
appendicitis further contributes to this field and our findings 
likely have implications for the design and delivery of other 
urgent care trials in children even where trial interventions 
are complex. Our work provides evidence for child health 
researchers contemplating ‘hard to do’ trials where poten-
tially eligible children often attend out of normal hours that 
such trials are feasible and acceptable particularly with iter-
ative training for recruiters. Through this feasibility trial, 
we are able for the first time to report on the safety of non- 
operative treatment for uncomplicated acute appendicitis 
in the UK. We acknowledge other reports of this treatment 
modality from overseas.13 14 This is an important aspect 
given the lack of familiarity with this treatment approach 
among most UK surgeons and further supports proceeding 
to a larger RCT. While we acknowledge an assessment of 
safety of non- operative treatment based on the relatively 
small numbers here should be made with caution, our find-
ings that there is no evidence of harm are in keeping with 
a growing body of literature suggesting that non- operative 
treatment is indeed a safe treatment approach.2 15 This 
finding is also timely, because more recently there has been 
a dramatic uptake of non- operative treatment for appendi-
citis during the SARS- CoV-2 pandemic in both adults and 
children.16 17 While there are several similar ongoing trials 
comparing non- operative treatment with appendicectomy 
for children with uncomplicated acute appendicitis,18 19 
none are recruiting in the UK. We continue to believe that a 
UK trial is important to understand the comparative effec-
tiveness of these two very different treatments and the 
comparative cost- effectiveness within the NHS. Given the 
Box 1 Recommendations to optimise informed consent, 
recruitment and retention in future paediatric urgent care 
surgical trials
1. Involve children and young people in research discussions 
and decision- making where possible, as per current guidance 
(1), while being sensitive to parents’ anxieties about what 
their children hear regarding treatment complications.
2. Provide families with advance information about how a 
child’s treatment will be managed prerandomisation and 
in both treatment arms. Where relevant, this should include 
the timing of trial treatments and the timeframe in which 
families should expect to see an improvement in their child’s 
conditions.
3. Parents may link treatment delays to the additional 
procedures required for the trial and this could discourage 
them from participating, or remaining, in the trial. Where 
possible, delays in delivering treatments prerandomisation 
and postrandomisation should be minimised.
4. In cases where children and parents differ in their treatment 
preferences, randomisation may offer a means of resolving 
this conflict. Sensitively explain treatment arm allocation to 
trial participants. If children are upset with their allocation, 
further exploring their treatment preference may help to allay 
their concerns.
5. Time to decide: develop a strategy to allow families to 
indicate when they have made a decision regarding 
participation, so minimising delays from the perspective of 
families.
6. Consider staffing strategies to support health professionals in 
recruiting families outside of normal working hours.
7. Be aware of family sensitivities when explaining postsurgery 
findings in the context of a trial.
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increase in use of non- operative treatment associated with 
the SARS- CoV-2 pandemic,17 understanding the outcomes of 
these different treatment approaches is arguably now more 
important than ever.
The clinical features and outcomes of participants in this 
feasibility RCT are not the focus of this report but some 
aspects are worthy of discussion in relation to feasibility of a 
future trial. Baseline characteristics of trial participants were 
as anticipated from the existing literature, suggesting that 
we have enrolled a representative population.8 20 Despite our 
efforts to only enrol children with uncomplicated appendi-
citis, 30% of children allocated to receive appendicectomy 
had complicated appendicitis. Our experience suggests that 
differentiating between uncomplicated and complicated 
disease based only on clinical judgement by a paediatric 
surgeon is inadequate both for a future RCT and future clin-
ical practice. Related to this is that we suspect the relatively 
low success rate of non- operative treatment reported here 
when compared with other studies2 is likely due to recruit-
ment of children with more advanced appendicitis than had 
been intended. Given the well- matched baseline characteris-
tics and randomised study design, we assume that a similar 
proportion in the non- operative treatment arm also had 
complicated appendicitis. For a future trial to be acceptable 
to all stakeholders therefore, it will be necessary to exclude 
those children with complicated appendicitis more reliably. 
Some similar studies have used ultrasound to make an assess-
ment of severity of appendicitis and thereby eligibility.13 18 21 
While seemingly attractive, the reliability of ultrasound is 
not 100% for this purpose and more importantly ultrasound 
is not routinely used for diagnostic purposes in the UK. In 
this trial, just 28% of participants received an ultrasound 
and in a recent large UK observational study, just 40% of 
children presenting with abdominal pain had an ultrasound.8 
Any trial protocol that demands ultrasound to assess eligi-
bility would limit the trial generalisability, limit the number 
available for recruitment and would not be representative 
of current UK practice. Instead, we intend to use a bespoke 
validated scoring system based on clinical and laboratory 
parameters; work is underway to develop this.
In conclusion, these data show that it is feasible to recruit 
children with uncomplicated acute appendicitis to a RCT 
comparing appendicectomy with non- operative treatment. 
There is no evidence for a poor safety profile of non- operative 
management. The comparative effectiveness of appendicectomy 
and non- operative treatment of uncomplicated acute appendi-
citis remains an important research question. The next step is 
to complete a definitive RCT with inclusion criteria modified to 
prevent recruitment of children with perforated appendicitis and 
this feasibility trial has been crucial in refining the design and 
implementation of that study.
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